Bristol-Myers Squibb
BMY
61.27
-0.98
-1.57%
Bristol-Myers Squibb
US · BMY
#122 by market cap
Listed 1970
-1.57%
61.27
-0.98
-1.57%
Live - 304 symbols - heartbeat 367s ago
· 2026-09-23 15:50
Pre-market
62.12
-0.21%
After-hours
62.30
+0.08%
Overnight
62.45
+0.32%
- Market cap
- 125.16B
- P/E (TTM)i
- 13.50
- P/Bi
- 5.61
- EPSi
- 3.46
- Div yieldi
- 4.10%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on BMY?
Anonymous reader poll. Unscientific, not investment advice.
About Bristol-Myers Squibb
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
- Founded
- 1933
- CEO
- Dr. Christopher S. Boerner, PhD
- Employees
- 32,500
- Headquarters
- Princeton, New Jersey, United States of America
- Fiscal year end
- 12-31
- Website
- bms.com
Company profile
- Exchange
- US
- Symbol
- BMY
- Market-cap rank
- #122
- Listing date
- 1970-01-01
- Market cap
- 125.16B
- Float cap
- 124.96B
- Shares out
- 2.04B
- Float shares
- 2.04B
Sectors & themes
Drug Manufacturers - General
Cancer Research
Government Pension Fund of Norway
Global medical industry
Regular Savings Plan
Fractional Shares JP
Star Stocks
Quote time 2026-09-23 15:50:03 · For reference only, not investment advice.